| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | -5.8% |
| Cost of Revenue | $9.4M | +33.6% |
| Gross Profit | $18.2M | -18.2% |
| R&D Expense | $52.9M | +105.4% |
| SG&A Expense | $112.1M | +425.1% |
| Operating Income | -$229.8M | -315.7% |
| Interest Expense | $1.2M | — |
| Pre-tax Income | -$242.2M | -338.0% |
| Income Tax | $465K | +503.9% |
| Net Income | -$242.6M | -338.2% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.7M | +51.1% |
| Accounts Receivable | $2.0M | +21.2% |
| Inventory | $4.6M | +110.1% |
| Current Assets | $70.7M | +54.7% |
| Total Assets | $81.2M | +57.1% |
| Current Liabilities | $24.5M | +14.5% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.7M | -96.2% |
| Capital Expenditures | $3.9M | +307.6% |
| Investing Cash Flow | -$3.9M | -3557.1% |
| Financing Cash Flow | $103.4M | +63.5% |
| Free Cash Flow | -$87.6M | -100.8% |
| Total Liabilities |
| $42.8M |
| -8.3% |
| Stockholders' Equity | $38.4M | +664.9% |